Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation

Myeloid sarcoma is a rare tumor consisting of myeloid blasts that involve anatomic sites outside the bone marrow. Fatal prognosis is inevitable in patients with extramedullary relapse after hematopoietic stem cell transplantation (HSCT), and no standard treatments are available yet. We report the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanna, Marco, Caocci, Giovanni, Vacca, Adriana, Piras, Eugenia, Orrù, Federica, La Nasa, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771481/
https://www.ncbi.nlm.nih.gov/pubmed/24066245
http://dx.doi.org/10.1155/2013/258028
_version_ 1782284209431248896
author Sanna, Marco
Caocci, Giovanni
Vacca, Adriana
Piras, Eugenia
Orrù, Federica
La Nasa, Giorgio
author_facet Sanna, Marco
Caocci, Giovanni
Vacca, Adriana
Piras, Eugenia
Orrù, Federica
La Nasa, Giorgio
author_sort Sanna, Marco
collection PubMed
description Myeloid sarcoma is a rare tumor consisting of myeloid blasts that involve anatomic sites outside the bone marrow. Fatal prognosis is inevitable in patients with extramedullary relapse after hematopoietic stem cell transplantation (HSCT), and no standard treatments are available yet. We report the first case of extramedullary relapse after HSCT treated with a combination of daunorubicin, cytarabine, and cladribine (DAC) regimen plus radiotherapy and donor lymphocyte infusion (DLI). This treatment induced a new and durable remission in our patient. The favorable toxicity profile and the reduced cost make this combination worthy of further investigations.
format Online
Article
Text
id pubmed-3771481
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37714812013-09-24 Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation Sanna, Marco Caocci, Giovanni Vacca, Adriana Piras, Eugenia Orrù, Federica La Nasa, Giorgio Case Rep Hematol Case Report Myeloid sarcoma is a rare tumor consisting of myeloid blasts that involve anatomic sites outside the bone marrow. Fatal prognosis is inevitable in patients with extramedullary relapse after hematopoietic stem cell transplantation (HSCT), and no standard treatments are available yet. We report the first case of extramedullary relapse after HSCT treated with a combination of daunorubicin, cytarabine, and cladribine (DAC) regimen plus radiotherapy and donor lymphocyte infusion (DLI). This treatment induced a new and durable remission in our patient. The favorable toxicity profile and the reduced cost make this combination worthy of further investigations. Hindawi Publishing Corporation 2013 2013-08-27 /pmc/articles/PMC3771481/ /pubmed/24066245 http://dx.doi.org/10.1155/2013/258028 Text en Copyright © 2013 Marco Sanna et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sanna, Marco
Caocci, Giovanni
Vacca, Adriana
Piras, Eugenia
Orrù, Federica
La Nasa, Giorgio
Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
title Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
title_full Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
title_fullStr Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
title_full_unstemmed Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
title_short Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
title_sort daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771481/
https://www.ncbi.nlm.nih.gov/pubmed/24066245
http://dx.doi.org/10.1155/2013/258028
work_keys_str_mv AT sannamarco daunorubicincytarabineandcladribineregimenplusradiotherapyanddonorlymphocyteinfusionforextramedullaryrelapseofacutemyeloidleukemiaafterhematopoieticstemcelltransplantation
AT caoccigiovanni daunorubicincytarabineandcladribineregimenplusradiotherapyanddonorlymphocyteinfusionforextramedullaryrelapseofacutemyeloidleukemiaafterhematopoieticstemcelltransplantation
AT vaccaadriana daunorubicincytarabineandcladribineregimenplusradiotherapyanddonorlymphocyteinfusionforextramedullaryrelapseofacutemyeloidleukemiaafterhematopoieticstemcelltransplantation
AT piraseugenia daunorubicincytarabineandcladribineregimenplusradiotherapyanddonorlymphocyteinfusionforextramedullaryrelapseofacutemyeloidleukemiaafterhematopoieticstemcelltransplantation
AT orrufederica daunorubicincytarabineandcladribineregimenplusradiotherapyanddonorlymphocyteinfusionforextramedullaryrelapseofacutemyeloidleukemiaafterhematopoieticstemcelltransplantation
AT lanasagiorgio daunorubicincytarabineandcladribineregimenplusradiotherapyanddonorlymphocyteinfusionforextramedullaryrelapseofacutemyeloidleukemiaafterhematopoieticstemcelltransplantation

Ejemplares similares